News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CERAM Helps Greatbatch Medical (GB) to Gain FDA Acceptance


8/21/2012 11:17:14 AM

(21 August 2012, Stoke-on-Trent, UK) - Ceram, the independent materials technology company, has recently helped Greatbatch Medical, providers of critical technologies used in medical devices, to gain FDA acceptance of its hydroxyapatite coating master file by providing all the necessary testing on the coating for a 510(k) implant submission.

In an effort to supply its French-produced coated devices marketed by its customers into the US market, Greatbatch Medical submitted a detailed hydroxyapatite coating master file to FDA in conjunction with the customer-submitted 510(k) submission. Ceram developed a comprehensive testing programme to supply sound and complete data and analysis to support the submission.

Working with implant manufacturers and bone replacement material suppliers, Ceram offers both a pre- and post-regulatory approval service to the medical device industry.

Dr Richard White, Head of Testing at Ceram, said:

“We are unique in that, thanks to our extensive analytical services, we can put together a complete testing regime for clients. Our aim is to take the guesswork out of what is needed to gain regulatory approval, by using our experience to put together all the chemical, physical and microstructural testing in a bespoke package. We then deliver credible data with full documentation and ongoing technical support.

“We congratulate Greatbatch Medical on achieving FDA acceptance and believe that the whole process has highlighted the value of working so closely together.”

Valéry Barbour, Quality Assurance - Customer Relation Manager, at Greatbatch Medical said:

“I would like to thank all of the Ceram team that has worked on this file during the last few months for its great involvement in the project, strong expertise and excellent responsiveness.

Working closely together allowed us to develop a comprehensive testing programme to fulfil FDA requirements for the submission of a hydroxyapatite coating master file.

“Ceram’s responsiveness to our questions really moved along the review of the file by FDA and we have really appreciated it! It was a challenging key milestone that we have successfully managed thanks to our new partnership.”

For more information about Ceram’s regulatory approval service visit www.ceram.com/reg-approval

About Ceram

Ceram is an independent, international materials technology company that focuses on innovation, sustainability and quality assurance of materials.

Headquartered in Staffordshire, UK, and with approved laboratories around the world, Ceram solves product and process challenges across a range of materials to help clients improve performance, comply with regulations and develop their sustainability performance in order to gain a competitive advantage and increase profitability.

Ceram operates in a wide variety of sectors around the world.

Mandy Rymill

Marketing Communications Manager

Tel. 44 (0)1782 764326


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES